YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
* CNS Pharmaceuticals press release [https://seekingalpha.com/pr/20616415-cns-pharmaceuticals-reports-second-quarter-2026-results-highlighting-strengthened-balance] (CNSP [https://seekingalpha.com/symbol/CNSP]): Q2 GAAP EPS of -$0.37 misse…
Quick Read NeOnc and Plus Therapeutics operate in the same CNS oncology space as CNS Pharmaceuticals but carry deeper pipelines, real funding, and commercial traction that can deliver near-term catalysts without the cash constraints and bi…
* CNS Pharmaceuticals press release [https://seekingalpha.com/pr/20515241-cns-pharmaceuticals-reports-first-quarter-2026-financial-results-and-highlights-strategic] (CNSP [https://seekingalpha.com/symbol/CNSP]): Q1 net loss was approximate…
Celcuity (CELC) reported late Friday positive topline results from a cohort of its phase 3 Viktoria- PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
* CNS Pharmaceuticals press release [https://seekingalpha.com/pr/20309728-cns-pharmaceuticals-reports-third-quarter-2025-financial-results-and-provides-corporate] (CNSP [https://seekingalpha.com/symbol/CNSP]): Q3 The net loss for the three…
As previously reported, Maxim upgraded CNS Pharmaceuticals (CNSP) to Buy from Hold with a $20 price target The company has pivoted to its oncology asset TPI-287, a blood brain barrier crossing taxane in development initially for recurrent…
In trading on Thursday, shares of Envista Holdings Corp (Symbol: NVST) crossed below their 200 day moving average of $19.02, changing hands as low as $18.88 per share. Envista Holdings Corp shares are currently trading down about 3.4% on t…
HOUSTON, TX / ACCESS Newswire / July 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the bra…
- Live video webcast presentations with participating companies - FRENCHTOWN, NJ / ACCESSWIRE / January 11, 2023 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the…
LOS ANGELES, Oct. 07, 2022 (GLOBE NEWSWIRE) -- InvestorWire -- CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the br…
- Live video webcast events on Thursday, April 14 at 10 AM ET, 11:30 AM ET and 1 PM ET - FRENCHTOWN, NJ / ACCESSWIRE / April 13, 2022 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announ…
- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast presentations of participating companies followed by interactive Q&A session - PITTSTOWN, NJ / ACCESSWIRE / January 12, 2022 /JTC Team…
Good morning, trader! Let’s start off the day right with a look into the biggest pre-market stock movers for Thursday! Wall Street building in the morning sun representing Pre-Market Stock Movers. Source: ventdusud / Shutterstock.com Loads…
Even though relentless efforts were made to contain the COVID-19 pandemic before 2021 bids adieu, the infection saw a renewed spike due to the latest Omicron variant. The deadly strain, suspected to be more contagious, again reminds invest…
Good morning, trader! We’re halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday! A view of the Federal Hall on Wall Street representing Pre-Market Stock Movers. Source: f11photo/Shutters…
- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast roundtable discussions with members of Management and Thought Leaders across participating companies - PITTSTOWN, NJ / ACCESSWIRE / Nov…
LOS ANGELES, Oct. 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and…
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV) Alkermes plc (NASDAQ: ALKS) Bio-Rad Laboratories, Inc. (NYSE: BIO)…
VANCOUVER, British Columbia, July 12, 2021 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical-stage pharmaceutical company, is pleased to announce that CNS Pharmaceuticals Inc. (“CNS”) (…
Bsquare (NASDAQ: BSQR) is a software development firm that is both Microsoft-embedded and an IoT partner. With offices in Seattle, Washington and Wiltshire in the UK, the firm supports manufacturers and operators worldwide with intelligent…
VANCOUVER, British Columbia, June 28, 2021 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical-stage pharmaceutical company, today provided an update on its Berubicin drug candidate clini…
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals (CSE:WBIO) (8SV1.F) ("WPD" or the “Company”) today announced that it has signed an agreement with CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) (“CNS”) to obtain…
WPD Pharmaceuticals plans to initiate a Berubicin Phase 2 adult GBM trial in the first half of 2021 and a multicenter pediatric malignant glioma Phase 1 clinical trial in 2021 CNS Pharmaceuticals plans to initiate a Berubicin adult GBM tri…
LOS ANGELES, Jan. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces that John Climaco, Chairman and CEO of CN…
HOUSTON, Dec. 28, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and cen…
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 17) Acceleron Pharma Inc (NASDAQ: XLRN) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) AtriCure In…
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 17) Acceleron Pharma Inc (NASDAQ: XLRN) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) AtriCure In…
LOS ANGELES, Dec. 16, 2020 (GLOBE NEWSWIRE) -- via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces that John Climaco, chairman and CEO of CN…
LOS ANGELES, Dec. 09, 2020 (GLOBE NEWSWIRE) -- via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces that John Climaco, Chairman & CEO of CNS…
HOUSTON, Nov. 24, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and cen…
HOUSTON, Sept. 24, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic ca…
Houston, Texas, Sept. 03, 2020 (GLOBE NEWSWIRE) -- via NetworkWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metasta…
Upgrades B of A Securities upgraded the previous rating for Deere & Co (NYSE: DE) from Neutral to Buy. Deere earned $2.57 in the third quarter, compared to $2.71 in the year-ago quarter. The stock has a 52-week-high of $202.95 and a 52-wee…
Upgrades B of A Securities upgraded the previous rating for Deere & Co (NYSE: DE) from Neutral to Buy. Deere earned $2.57 in the third quarter, compared to $2.71 in the year-ago quarter. The stock has a 52-week-high of $202.95 and a 52-wee…
Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com NEW YORK, June 23, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its second quarterly even…
NEW YORK, May 27, 2020 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading in CNS Pharmaceuticals Inc. (Nasdaq: CNSP) is scheduled to resume on Thursday, May 28, 2020, at 7:00 a.m. Eastern Time. Trading in th…